Exelixis, Inc.
USD55.53
-0.39 (-0.70%)
CEO
Michael Morrissey
IPO Date
2000-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$56.11
Prev. Close
$55.92
Day Low
$55.50
Day High
$56.69
52W Low
$33.76
52W High
$57.57
Market Cap
$13.96B
Volume
2.35M
| 9,812 |
| $50.14 |
| 29 May 2026 | JOHNSON DAVID EDWARD | director | A-Award | Acquired | 19,133 | $50.03 |
| 29 May 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Heyman Tomas J. | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Eckhardt Sue Gail | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Smith Julie | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Freire Maria C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Beckerle Mary C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Oliver Bob | director | A-Award | Acquired | 8,367 | $0.00 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |